Multiple Sclerosis National Research Institute
Multiple Sclerosis National Research Institute's Fundraiser

We can expand disease research areas

Join us and help make a difference, please give today.

$400 towards $5,000

Multiple Sclerosis National Research Institute is a division of Torrey Pines Institute for Molecular Studies, a not-for-profit basic research center dedicated to the discovery and development of innovative research methods that lead to treatments for major medical conditions, including multiple sclerosis, AIDS, Alzheimer's disease, pain, heart disease, many types of cancer, and more.

Our group at Multiple Sclerosis National Research Institute works specifically on a variety of approaches towards understanding multiple sclerosis, including its causes, how its various forms progress, treatments of its symptoms, and even treatments which could someday lead to its prevention and/or cure.

Our research is supported in part by grants from the National Institutes of Health ("NIH"). Donations we receive from the public are used in many ways to support these important research projects. For example, some grants do not fully support the entire cost of a given research project. Public donations are also used to purchase equipment needed by these laboratories.

Our scientists are now able to attend many international conferences each year, with support received from donations. We are now able to fund projects which are not supported by other grant mechanisms, including new approaches that would typically not receive external funding due to a lack of early experimental data. Using these funds as "seed money", we are able to support both new scientists starting in the field as well as established scientists who wish to try a new approach to an old question.

By working together with other granting agencies, we believe that progress will be made even more rapidly than ever before. We are proud to combine resources and scientific knowledge with others throughout the world, as we all work towards understanding multiple sclerosis.